0
0
25 words
0
Comments
Argenx's antibody treatment, Vyvgart, significantly delayed the progression of an autoimmune nerve disorder called CIPD.
You are the first to view
https://www.statnews.com/2023/07/17/vyvgart-cipd-argenx-chronic-inflammatory-demylinating-polyneuropathy/
Create an account or login to join the discussion